![A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820300260-fx1.jpg)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
![Summary Of Active Clinical Trials For Prader-Willi Syndrome Hyperphagia - Prader-Willi Syndrome Association | USA Summary Of Active Clinical Trials For Prader-Willi Syndrome Hyperphagia - Prader-Willi Syndrome Association | USA](https://www.pwsausa.org/wp-content/uploads/2020/05/PWS-Clinical-Trial-Table-2018-03-21-Combined-1.jpg)
Summary Of Active Clinical Trials For Prader-Willi Syndrome Hyperphagia - Prader-Willi Syndrome Association | USA
![A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41436-020-01006-8/MediaObjects/41436_2020_1006_Fig1_HTML.png)
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
![Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized ... Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized ...](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/972b5400-906f-47ba-9ca4-7a77f290d3c9/dom.2019.21.issue-8.cover.jpg)
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized ...
![PDF) GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial PDF) GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial](https://i1.rgstatic.net/publication/235521451_GI-REASONS_a_novel_6-month_prospective_randomized_open-label_blinded_end_point_PROBE_trial/links/02d676580cf2935210328d5b/largepreview.png)
PDF) GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
![Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers](https://data01.123doks.com/thumbv2/123dok_us/001/352/1352435/cover.webp)
Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers
![Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial - The Lancet Neurology Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000992320/2003665170/gr1.gif)
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial - The Lancet Neurology
![PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a0653b7b38e796366a33a888639ab58e6f15b68e/4-Figure1-1.png)
PDF] GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | Semantic Scholar
![Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study - The Lancet Neurology Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d957d5b-e72f-459d-bf04-15feb7eae952/gr1.gif)
Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study - The Lancet Neurology
![Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-020-05548-2/MediaObjects/213_2020_5548_Fig1_HTML.png)
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink
![Frontiers | Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68 | Medicine Frontiers | Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68 | Medicine](https://www.frontiersin.org/files/MyHome%20Article%20Library/501035/501035_Thumb_400.jpg)
Frontiers | Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68 | Medicine
PLOS Medicine: Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
![Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ... Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ...](https://cyberleninka.org/viewer_images/1315642/f/1.png)
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care ...
![1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events. - ppt download 1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events. - ppt download](https://slideplayer.com/4289547/14/images/slide_1.jpg)
1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events. - ppt download
![A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study | Semantic Scholar A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a80a8b9dcae6dce8ccd42713ad1e8fcf798c1403/4-Table2-1.png)
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study | Semantic Scholar
![PDF) Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study | Dheeraj Kalladka - Academia.edu PDF) Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study | Dheeraj Kalladka - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/53971711/mini_magick20190118-19983-crxcrm.png?1547864833)
PDF) Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study | Dheeraj Kalladka - Academia.edu
![An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-017-0172-9/MediaObjects/13601_2017_172_Fig1_HTML.gif)
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full
![Effect of Postconditioning on Myocardial Reperfusion during Primary Percutaneous Coronary Intervention Joo-Yong Hahn / Hyeon-Cheol Gwon On behalf of the. - ppt video online download Effect of Postconditioning on Myocardial Reperfusion during Primary Percutaneous Coronary Intervention Joo-Yong Hahn / Hyeon-Cheol Gwon On behalf of the. - ppt video online download](https://slideplayer.com/slide/7814977/25/images/5/Trial+Design+A+multicenter%2C+prospective%2C+randomized%2C+open-label%2C+blinded+endpoint+%28PROBE%29+trial.+STEMI+patients+undergoing+primary+PCI..jpg)